About 293,295 results

Global COVID cases rise as BA.4 and BA.5 expand
CIDRAP - Center for Infectious Disease Research and Policy; Schnirring L.

Jul 29th, 2022 - COVID-19 cases jumped 18% last week and are at their highest levels since April, and the increase comes as the more transmissible Omicron BA.4 and BA.5 subvariants cause most infections, the World Health Organization (WHO) said today in its latest update.

RECOVER Researchers Express Hope and Frustration in Their Study of Long COVID
MedPage Today; DePeau-Wilson M.

Jul 23rd, 2022 - Slow enrollment has led to simmering frustrations over the progress and potential of the NIH's RECOVER Initiative, the research consortium focused on studying post-acute sequelae of SARS-CoV-2, or long COVID, according to researchers and leaders within the initiative. The RECOVER Initiative was designed to support research on long COVID across the U.S., including among every group of people ...

Then and now: A ‘lifetime’ of advancement in upper GI
David A. Katzka, MD, MDedge News

Jul 1st, 2022 - Fifteen years is a lifetime for the advancement of medical research. This seems particularly true for upper GI tract disorders.

Exocrine Pancreatic Insufficiency: Risk Factors and Management Approaches
Jodie Barkin, MD,, MDedge News

Jul 1st, 2022 - What characteristics or symptoms do you look for to identify patients who are at risk for exocrine pancreatic insufficiency (EPI)? Dr. Barkin: The first thing we have to understand is which patient populations we should consider.

Insurer Delays Prior Authorization, Patient Loses Leg and Pelvis, Then Dies

Jul 1st, 2022 - North Carolina patient Kathleen Valentini was referred to an orthopedic surgeon after experiencing excruciating pain in her hip that continued to worsen. When an x-ray failed to reveal the cause, the orthopedic surgeon ordered an MRI to determine the source of Valentini's symptoms. Valentini's insurer, however, denied coverage of the MRI, saying that it was medically unnecessary. Group Health I...

Study Confirms Increased CVT With AstraZeneca COVID Vaccine

Jul 1st, 2022 - A new Scandinavian study has confirmed previous data showing increased rates of cerebral venous thrombosis and thrombocytopenia after the AstraZeneca COVID-19 vaccine. The study also showed higher rates of several thromboembolic and thrombocytopenic outcomes after the Pfizer and Moderna mRNA vaccines, although these increases were less than the rates observed after the AstraZeneca vaccine, and ...

Will ESD replace EMR for large colorectal polyps?
Sumeet K. Tewani, MD, Alexis Bayudan, MD et. al.

Jun 30th, 2022 - Dear colleagues, Resection of polyps is the bread and butter of endoscopy. Advances in technology have enabled us to tackle larger and more complex lesions throughout the gastrointestinal tract, especially through endoscopic mucosal resection (EMR).

‘The Rock’ assumes the presidency of AGA

Jun 30th, 2022 - We’re honored to announce that John M. Carethers, MD, AGAF, affectionately nicknamed ‘The Rock,’ will begin his term as the 117th president of the AGA Institute on June 1, 2022.

New AGA Research Foundation Executive Board members

Jun 30th, 2022 - We’re pleased to share that Michael Camilleri, MD, AGAF, will be taking over the AGA Research Foundation chair role beginning this month. He has recruited five members to be part of the 2022-2024 AGA Research Foundation Executive Board.

Mobile devices ‘addictive by design’: Obesity is one of many health effects
Ted Bosworth

Jun 30th, 2022 - Wireless devices, like smart phones and tablets, appear to induce compulsive or even addictive use in many individuals, leading to adverse health consequences that are likely to be curtailed only through often difficult behavior modification, according to a pediatric endocrinologist’s take on the problem. While the summary was based in part on the analysis of 234 published papers drawn from the.

Updates in Aspirin Use, Aducanumab, and CKD Diagnosis in Geriatric Care

Jun 30th, 2022 - This article originally appeared on MDedge.com. The following highlights are a brief overview of guideline updates, drug approvals, and diagnostics relevant to geriatric medicine from June 2021 to April 2022, some of which were discussed at the American Geriatrics Society conference in May. I selected these topics as they were among the most discussed by my colleagues in geriatric medicine and ...

Diabetic Neuropathy Associated With Chewing Difficulty

Jun 30th, 2022 - Neuropathy was associated with masticatory (chewing) dysfunction independent of missing teeth or diabetes severity in a small study in Japan. "We demonstrated that patients with type 2 diabetes who developed diabetic neuropathy had significantly reduced masticatory efficiency," Yuta Hamamoto, DDS, PhD, and colleagues report in a study published online in PLoS One. The decreased chewing ability ...

Specific Genetic Mutations Predict Parkinson's Disease Survival

Jun 30th, 2022 - Specific genetic mutations may predict survival in patients with Parkinson's disease (PD), new research suggests. Results from a retrospective study showed that compared with patients who had no mutation, those with an SNCA or GBA mutation had a significantly shorter survival time, whereas patients with an LRRK2 or PRKN mutation had a longer survival time. Dr Aymeric Lanore Information on genet...

High Rate of Undiagnosed Major Risk Factors in Ischemic Stroke

Jun 30th, 2022 - Almost two thirds of patients with acute ischemic stroke have at least one undiagnosed major risk factor, new research shows. The most common of these are dyslipidemia, hypertension, and atrial fibrillation (AF). In addition, many of the study participants were women and were relatively younger. André Rêgo, MD These results highlight the need for greater clinician awareness about how this pat...

Irritable Bowel Syndrome Therapy Removed From Market (Again)

Jun 30th, 2022 - Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from the US market effective June 30, according to the manufacturer, Alfasigma. The Italian pharmaceutical company said the drug is being removed for business purposes, not because of any concern involving its safety or efficacy, nor has it been recalled. The drug has been th...

Diabetes Devices May Give Kids Contact Dermatitis

Jun 30th, 2022 - Devices that help children control their diabetes and lead fuller lives may also give them contact dermatitis, report the authors of a new study that calls for mandatory labeling of ingredients for allergy patch testing. "A high share of patients showed positive reactions to isobornyl acrylate adhesive (IBOA) and/or their medical devices (insulin pumps or glucose devices)," the study authors wr...

What Are the Benefits of a Fourth Vaccination Against COVID?

Jun 30th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The fourth vaccination against COVID-19 is the subject of intense discussion. Immunity against new Omicron variants (currently BA.4 and BA.5) is getting weaker and weaker. Is another vaccination with the available vaccines worth it? For Leif Erik Sander, MD, director of infectious diseases and p...

After Childhood Cancer, Racial Minorities Face Worse Outcomes

Jun 30th, 2022 - Childhood cancer survivors from racial minority groups face disproportionately increased risks for hospitalization for various physical and mental health conditions, new research shows. "Racial and ethnic minority survivors of childhood cancer may have increased long-term disease burden and a range of conditions that require hospitalizations and compound medical costs, shorten life expectancy, ...

Fireworks-Related Injuries Up 25% Over Last 15 Years: CPSC

Jun 30th, 2022 - Fireworks-related injuries are rising in the U.S., according to a new report from the Consumer Product Safety Commission released ahead of the country's Independence Day. The commission said in the report released on Wednesday that fireworks-related injuries have seen a "significant upward trend" over the past 15 years, increasing by 25% since 2006. In 2021 alone, there were an estimated 11,500...

Fauci Says He Had Paxlovid Rebound, Worse Symptoms

Jun 30th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Anthony Fauci, MD, the chief medical adviser to President Joe Biden, said Tuesday that he went through a "Paxlovid rebound" that can occur after taking the antiviral to recover from COVID-19. The symptoms that he had after he completed the treatment were more severe than those he had at first fr...